AKT1 and neoplasm: It was found that formononetin could significantly inhibit the PI3K/AKT signaling pathway to induce the apoptosis of cervical cancer HeLa cells and suppress xenograft tumor growth in nude mice, which indicated that formononetin may be used as an anti-cancer drug for cervical cancer in the future [120] (Figure 41).